(Q63952641)

English

In the coming year we should abandon interferons and glatiramer acetate as first line therapy for MS: Commentary

scientific article published on 01 January 2013

Statements

In the coming year we should abandon interferons and glatiramer acetate as first line therapy for MS: commentary (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit